Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. [electronic resource]
Producer: 20020418Description: 242-7 p. digitalISSN:- 0171-967X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Bone Density -- drug effects
- Bone and Bones -- drug effects
- Calcium Channel Blockers -- therapeutic use
- Dose-Response Relationship, Drug
- Double-Blind Method
- Etidronic Acid -- analogs & derivatives
- Humans
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Prednisone -- adverse effects
- Risedronic Acid
- Spinal Fractures -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.